
    
      Prospective, randomized (1:1) controlled, single blind, single center study in 2000
      percutaneous coronary intervention (PCI) patients comparing the ExoSeal VCD (test device) to
      the AngioSeal VCD (standard comparator). In-hospital and 30 days safety and efficacy
      endpoints and 6 months safety endpoints will be reported.
    
  